FDA approves lenvatinib plus pembrolizumab for advanced renal cell carcinoma

FDA approves lenvatinib plus pembrolizumab for advanced renal cell carcinoma

http://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lenva...

Source: FDA Center for Drug Evaluation and Research - What's New - August 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Kidney Cancer | Renal Cell Carcinoma